Literature DB >> 3300317

Effect of inoculum size on in vitro activity of norfloxacin against fecal anaerobic bacteria. Rationale for selective decontamination of the digestive tract.

E J Goldstein, D M Citron, M L Corrado.   

Abstract

Previous studies have shown that anaerobic bacteria are susceptible to norfloxacin at the levels attained in the feces. Conversely, studies in laboratory animals and neutropenic humans using norfloxacin for selective decontamination of the digestive tract have shown that norfloxacin markedly reduces the aerobic enteric flora without reducing fecal anaerobic flora. In an effort to resolve this paradox, the effect of a 10(9) colony-forming units (cfu)/ml inoculum, which is more reflective of actual fecal counts than the standard 10(5) cfu/ml inoculum, on the activity of norfloxacin against two fecal Escherichia coli isolates and 16 fecal anaerobic isolates was studied. The results showed a marked inoculum effect at 10(9) cfu/ml for most anaerobic isolates but not for the E. coli strains tested. At 256 micrograms/ml, all E. coli were killed while the anaerobic bacteria maintained colony counts greater than or equal to 10(9) cfu/ml. Hence, the lack of anaerobic activity (minimal inhibitory concentration greater than or equal to 512 micrograms/ml) at higher fecal inocula might explain the utility of norfloxacin in selective decontamination of the bowel.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3300317     DOI: 10.1016/0002-9343(87)90625-5

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  11 in total

Review 1.  Quinolone antimicrobial agents: adverse effects and bacterial resistance.

Authors:  J S Wolfson
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

2.  Comparison of the inoculum effects of members of the family Enterobacteriaceae on cefoxitin and other cephalosporins, beta-lactamase inhibitor combinations, and the penicillin-derived components of these combinations.

Authors:  E J Goldstein; D M Citron; C E Cherubin
Journal:  Antimicrob Agents Chemother       Date:  1991-03       Impact factor: 5.191

Review 3.  Role of quinolones in surgical prophylaxis.

Authors:  L A Mandell
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-04       Impact factor: 3.267

4.  Effects of single oral doses of gemifloxacin (320 milligrams) versus trovafloxacin (200 milligrams) on fecal flora in healthy volunteers.

Authors:  G Garcia-Calvo; A Molleja; M J Giménez; A Parra; E Nieto; C Ponte; L Aguilar; F Soriano
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

5.  A norfloxacin dose finding study for selective decontamination of the digestive tract in pigs.

Authors:  L A Van der Waaij; O Messerschmidt; D Van der Waaij
Journal:  Epidemiol Infect       Date:  1989-02       Impact factor: 2.451

Review 6.  Impact of the fluoroquinolones on gastrointestinal flora.

Authors:  V Korten; B E Murray
Journal:  Drugs       Date:  1993       Impact factor: 9.546

7.  Susceptibility of anaerobic bacteria isolated from intra-abdominal infections to ofloxacin and interaction of ofloxacin with metronidazole.

Authors:  E J Goldstein; D M Citron
Journal:  Antimicrob Agents Chemother       Date:  1991-11       Impact factor: 5.191

Review 8.  Quinolones and the gastrointestinal tract.

Authors:  B E Murray
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1989-12       Impact factor: 3.267

9.  Norfloxacin binds to human fecal material.

Authors:  C Edlund; L Lindqvist; C E Nord
Journal:  Antimicrob Agents Chemother       Date:  1988-12       Impact factor: 5.191

Review 10.  Fluoroquinolone antimicrobial agents.

Authors:  J S Wolfson; D C Hooper
Journal:  Clin Microbiol Rev       Date:  1989-10       Impact factor: 26.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.